The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 mice

Cellular Immunology

Volumn 266, Issue 1, 2010, Pages 14-23

  MacLeod, Heather ^a   Goodwin, Debra G ^b   Damphousse, Christy ^b   Lonie, Elisabeth ^b   Xu, Xin ^b   Collins, Mary ^b   Nickerson Nutter, Cheryl L ^b  

^a NOVARTIS PHARMA K K   (Japan)

^b PFIZER INC   (United States)

Author keywords

Cell signaling; Costimulation; CTLA 4; Cyclosporine A; Cytokines; Delayed type hypersensitivity; IL 2; MTOR; T cells; Temsirolimus

Indexed keywords

ABATACEPT; CD28 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 2; TEMSIROLIMUS; TRANSCRIPTION FACTOR NFAT;

ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SWELLING;

ANIMALS; ANTIBODIES; ANTIGENS, CD28; AUTOIMMUNITY; CELL MOVEMENT; CYCLOSPORINE; CYTOKINES; ERYTHROCYTES; FEMALE; FOOT; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOCONJUGATES; INTERLEUKIN-17; INTERLEUKIN-2; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; NFATC TRANSCRIPTION FACTORS; PROTEIN KINASE INHIBITORS; PROTEINS; SHEEP; SIGNAL TRANSDUCTION; SIROLIMUS; SPECIES SPECIFICITY; T-LYMPHOCYTES; VACCINATION;

MUS;

EID: 77958483990     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.08.005     Document Type: Article

References (50)

1. Hurtrel B., Maire M.A., Hurtrel M., Lagrange P.H. Different time course patterns of local expression of delayed-type hypersensitivity to sheep red blood cells in mice. Cell. Immunol. 1992, 142:252-263.
2. Huber B., Cantor H., Shen F.W., Boyse E.A. Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses. J. Exp. Med. 1976, 144:1128-1133.
3. Mitsuoka A., Teramatsu T., Baba M., Morikawa S., Yasuhira K. Delayed hypersensitivity in mice induced by intravenous sensitization with sheep erythrocytes: evidence for tuberculin type delayed hypersensitivity of the reaction. Immunology 1978, 34:363-370.
4. Diamantstein T., Eckert R., Volk H.D., Kupier-Weglinski J.W. Reversal by interferon-gamma of inhibition of delayed-type hypersensitivity induction by anti-CD4 or anti-interleukin 2 receptor (CD25) monoclonal antibodies. Evidence for the physiological role of the CD4+ TH1+ subset in mice. Eur. J. Immunol. 1988, 18:2101-2103.
5. Kelley V.E., Gaulton G.N., Strom T.B. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope. J. Immunol. 1987, 138:2771-2775.
6. Miller S.D., Jenkins M.K. In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivity. Cell. Immunol. 1985, 92:414-426.
7. Cobbold S.P., Jayasuriya A., Nash A., Prospero T.D., Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984, 312:548-551.
8. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L.L., Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993, 366:76-79.
9. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 1991, 173:721-730.
10. Pihlgren M., Dubois P.M., Tomkowiak M., Sjogren T., Marvel J. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J. Exp. Med. 1996, 184:2141-2151.
11. Rogers P.R., Dubey C., Swain S.L. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J. Immunol. 2000, 164:2338-2346.
12. Croft M., Bradley L.M., Swain S.L. Naive versus memory CD4 T cell response to antigen, memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 1994, 152:2675-2685.
13. Luqman M., Bottomly K. Activation requirements for CD4+ T cells differing in CD45R expression. J. Immunol. 1992, 149:2300-2306.
14. Byrne J.A., Butler J.L., Cooper M.D. Differential activation requirements for virgin and memory T cells. J. Immunol. 1988, 141:3249-3257.
15. Weiss A. Structure and function of the T cell antigen receptor. J. Clin. Invest. 1990, 86:1015-1022.
16. Imboden J.B., Stobo J.D. Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 1985, 161:446-456.
17. Weiss A., Imboden J.B. Cell surface molecules and early events involved in human T lymphocyte activation. Adv. Immunol. 1987, 41:1-38.
18. Timmerman L.A., Clipstone N.A., Ho S.N., Northrop J.P., Crabtree G.R. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 1996, 383:837-840.
19. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992, 357:695-697.
20. Durand D.B., Shaw J.P., Bush M.R., Replogle R.E., Belagaje R., Crabtree G.R. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 1988, 8:1715-1724.
21. Tarayre J.P., Barbara M., Aliaga M., Tisne-Versailles J. Comparative actions of immunosuppressants, glucocorticoids and non-steroidal anti-inflammatory drugs on various models of delayed hypersensitivity and on a non-immune inflammation in mice. Arzneimittelforschung 1990, 40:1125-1131.
22. Noori S., Naderi G.A., Hassan Z.M., Habibi Z., Bathaie S.Z., Hashemi S.M. Immunosuppressive activity of a molecule isolated from Artemisia annua on DTH responses compared with cyclosporin A. Int. Immunopharmacol. 2004, 4:1301-1306.
23. Thomson A.W., Moon D.K., Nelson D.S. Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin. Exp. Immunol. 1983, 52:599-606.
24. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
25. Friedman J., Weissman I. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 1991, 66:799-806.
26. Kronke M., Leonard W.J., Depper J.M., Arya S.K., Wong-Staal F., Gallo R.C., Waldmann T.A., Greene W.C. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc. Natl. Acad. Sci. USA 1984, 81:5214-5218.
27. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991, 174:561-569.
28. Young D.A., Nickerson-Nutter C.L. mTOR - beyond transplantation. Curr. Opin. Pharmacol. 2005, 5:418-423.
29. Howard L.M., Kohm A.P., Castaneda C.L., Miller S.D. Therapeutic blockade of TCR signal transduction and co-stimulation in autoimmune disease. Curr. Drug Targets Inflamm. Allergy 2005, 4:205-216.
30. Stuart R.W., Racke M.K. Targeting T cell costimulation in autoimmune disease. Expert Opin. Ther. Targets 2002, 6:275-289.
31. Li L., Elliott J.F., Mosmann T.R. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 1994, 153:3967-3978.
32. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
33. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., Yi J., Guentert T., Tousson A., Stanus A.L., Le T.V., Lorenz R.G., Xu H., Kolls J.K., Carter R.H., Chaplin D.D., Williams R.W., Mountz J.D. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 2008, 9:166-175.
34. June C.H., Ledbetter J.A., Gillespie M.M., Lindsten T., Thompson C.B. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 1987, 7:4472-4481.
35. Thompson C.B., Lindsten T., Ledbetter J.A., Kunkel S.L., Young H.A., Emerson S.G., Leiden J.M., June C.H. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 1989, 86:1333-1337.
36. Ghosh P., Buchholz M.A., Yano S., Taub D., Longo D.L. Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway. Blood 2002, 99:4517-4524.
37. Mountz J.D., Yang P., Wu Q., Zhou J., Tousson A., Fitzgerald A., Allen J., Wang X., Cartner S., Grizzle W.E., Yi N., Lu L., Williams R.W., Hsu H.C. Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand. J. Immunol. 2005, 61:128-138.
38. Cher D.J., Mosmann T.R. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J. Immunol. 1987, 138:3688-3694.
39. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991, 146:3444-3451.
40. Nambu A., Nakae S., Iwakura Y. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses. Int. Immunol. 2006, 18:701-712.
41. Higashi N., Yoshizuka N., Kobayashi Y. Phenotypic properties and cytokine production of skin-infiltrating cells obtained from guinea pig delayed-type hypersensitivity reaction sites. Cell. Immunol. 1995, 164:28-35.
42. Higashi N., Yoshizuka N., Ohuchi A., Osawa T., Kobayashi Y. Involvement of inflammatory cytokines in a delayed-type hypersensitivity reaction. Cell. Immunol. 1995, 161:288-294.
43. Mondino A., Mueller D.L. mTOR at the crossroads of T cell proliferation and tolerance. Semin. Immunol. 2007, 19:162-172.
44. Fayen J.D. Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway. Immunology 2001, 104:299-306.
45. Desai-Mehta A., Lu L., Ramsey-Goldman R., Datta S.K. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 1996, 97:2063-2073.
46. Yellin M.J., Thienel U. T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules. Curr. Rheumatol. Rep. 2000, 2:24-31.
47. Carlson R.P., Baeder W.L., Caccese R.G., Warner L.M., Sehgal S.N. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases. Ann. NY Acad. Sci. 1993, 685:86-113.
48. Pai S.Y., Fruman D.A., Leong T., Neuberg D., Rosano T.G., McGarigle C., Antin J.H., Bierer B.E. Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A. Blood 1994, 84:3974-3979.
49. Larsen C.P., Elwood E.T., Alexander D.Z., Ritchie S.C., Hendrix R., Tucker-Burden C., Cho H.R., Aruffo A., Hollenbaugh D., Linsley P.S., Winn K.J., Pearson T.C. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996, 381:434-438.
50. Wu Y., Liu J., Feng X., Yang P., Xu X., Hsu H.C., Mountz J.D. Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis. Arthritis Rheum. 2005, 52:3257-3268. (see comment).